AI assistant
Sending…
Sopharma AD — Earnings Release 2018
Dec 5, 2018
2543_rns_2018-12-05_fc312d03-1ab1-44ea-b4c2-7bee33bcc474.pdf
Earnings Release
Open in viewerOpens in your device viewer
Current report No. 142 / 2018 Dated December 5, 2018
NOTIFICATION
Sopharma AD (the "Company") notifies that for November 2018 the Company recorded a decrease of sales revenues of 9% compared to the same month of 2017, including 10% increase of domestic sales and a decrease of 23% of export sales.
In the eleven months of 2018 revenue from sales of goods decreased by 6% compared to the same period in 2017, incl. 4% decrease in sales for the domestic market and 7% decrease in export sales.
Signatures of individuals authorized to represent the Company:
Ognian Donev
More from Sopharma AD
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20
Transaction in Own Shares
2026
May 19
Transaction in Own Shares
2026
May 18
Transaction in Own Shares
2026
May 15
Transaction in Own Shares
2026
May 14
Transaction in Own Shares
2026
May 13